JUNIPER NETWORKS INC, 10-Q filed on 4/28/2023
Quarterly Report
v3.23.1
Cover Page - shares
3 Months Ended
Mar. 31, 2023
Apr. 26, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-34501  
Entity Registrant Name JUNIPER NETWORKS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0422528  
Entity Address, Address Line One 1133 Innovation Way  
Entity Address, City or Town Sunnyvale,  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94089  
City Area Code 408  
Local Phone Number 745-2000  
Title of 12(b) Security Common Stock, par value $0.00001 per share  
Trading Symbol JNPR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   321,592,106
Entity Central Index Key 0001043604  
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Total net revenues $ 1,371.8 $ 1,168.2
Cost of revenues:    
Total cost of revenues 600.6 518.8
Gross margin 771.2 649.4
Operating expenses:    
Research and development 284.8 248.6
Sales and marketing 303.2 273.3
General and administrative 68.0 60.2
Restructuring (benefits) charges (0.5) 8.8
Total operating expenses 655.5 590.9
Operating income 115.7 58.5
Other expense, net (8.6) (12.9)
Income before income taxes and loss from equity method investment 107.1 45.6
Income tax provision (benefit) 19.6 (10.1)
Loss from equity method investment, net of tax (2.1) 0.0
Net income $ 85.4 $ 55.7
Net income per share:    
Basic (in dollars per share) $ 0.26 $ 0.17
Diluted (in dollars per share) $ 0.26 $ 0.17
Weighted-average shares used to compute net income per share:    
Basic (in shares) 322.3 321.8
Diluted (in shares) 329.1 331.1
Product    
Total net revenues $ 912.6 $ 744.3
Cost of revenues:    
Total cost of revenues 454.9 378.5
Service    
Total net revenues 459.2 423.9
Cost of revenues:    
Total cost of revenues $ 145.7 $ 140.3
v3.23.1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Comprehensive Income [Abstract]    
Net income $ 85.4 $ 55.7
Available-for-sale debt securities:    
Change in net unrealized gains and losses 2.1 (5.7)
Net realized losses reclassified into net income 0.0 0.1
Net change on available-for-sale debt securities 2.1 (5.6)
Cash flow hedges:    
Change in net unrealized gains and losses (6.9) 20.8
Net realized losses reclassified into net income 7.4 0.1
Net change on cash flow hedges 0.5 20.9
Change in foreign currency translation adjustments 1.5 (1.5)
Other comprehensive income, net 4.1 13.8
Comprehensive income $ 89.5 $ 69.5
v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 923.5 $ 880.1
Short-term investments 174.9 210.3
Accounts receivable, net of allowances 1,061.8 1,227.3
Inventory 761.5 619.4
Prepaid expenses and other current assets 736.4 680.0
Total current assets 3,658.1 3,617.1
Property and equipment, net 671.0 666.8
Operating lease assets 132.7 141.6
Long-term investments 92.6 139.6
Purchased intangible assets, net 143.3 160.5
Goodwill 3,734.4 3,734.4
Other long-term assets 884.2 866.7
Total assets 9,316.3 9,326.7
Current liabilities:    
Accounts payable 357.5 347.4
Accrued compensation 228.4 306.1
Deferred revenue 1,074.3 1,020.5
Other accrued liabilities 414.0 404.9
Total current liabilities 2,074.2 2,078.9
Long-term debt 1,616.7 1,601.3
Long-term deferred revenue 685.6 642.6
Long-term income taxes payable 279.8 279.4
Long-term operating lease liabilities 105.5 117.7
Other long-term liabilities 119.3 131.7
Total liabilities 4,881.1 4,851.6
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock, $0.00001 par value; 10.0 shares authorized; none issued and outstanding 0.0 0.0
Common stock, $0.00001 par value; 1,000.0 shares authorized; 321.4 shares and 322.9 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 0.0 0.0
Additional paid-in capital 6,808.1 6,846.4
Accumulated other comprehensive income 8.3 4.2
Accumulated deficit (2,381.2) (2,375.5)
Total stockholders' equity 4,435.2 4,475.1
Total liabilities and stockholders' equity $ 9,316.3 $ 9,326.7
v3.23.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock - par value (in dollars per share) $ 0.00001 $ 0.00001
Preferred stock - shares authorized (in shares) 10,000,000.0 10,000,000.0
Preferred stock - issued (in shares) 0 0
Preferred stock - outstanding (in shares) 0 0
Common stock - par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock - shares authorized (in shares) 1,000,000,000 1,000,000,000
Common stock - issued (in shares) 321,400,000 322,900,000
Common stock - outstanding (in shares) 321,400,000 322,900,000
v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 85.4 $ 55.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Share-based compensation expense 60.9 45.2
Depreciation, amortization, and accretion 49.4 56.3
Operating lease assets expense 10.1 10.1
Loss from equity method investment 2.1 0.0
Other 3.7 6.8
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net 166.1 145.5
Inventory [1] (145.7) (47.8)
Prepaid expenses and other assets (84.3) (105.9)
Accounts payable 15.4 44.6
Accrued compensation (78.4) (95.4)
Income taxes payable 29.6 25.5
Other accrued liabilities (19.0) (0.7)
Deferred revenue 96.2 53.2
Net cash provided by operating activities 191.5 193.1
Cash flows from investing activities:    
Purchases of property and equipment (42.1) (25.0)
Purchases of available-for-sale debt securities (5.0) (58.1)
Proceeds from sales of available-for-sale debt securities 14.0 33.3
Proceeds from maturities and redemptions of available-for-sale debt securities 69.4 123.6
Purchases of equity securities (2.4) (9.3)
Proceeds from sales of equity securities 7.4 2.2
Payments for business acquisitions, net of cash and cash equivalents acquired 0.0 (3.3)
Other 0.9 0.5
Net cash provided by investing activities 42.2 63.9
Cash flows from financing activities:    
Repurchase and retirement of common stock (151.3) (126.3)
Proceeds from issuance of common stock 31.1 28.6
Payment of dividends (70.6) (67.5)
Net cash used in financing activities (190.8) (165.2)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash 1.2 (1.7)
Net increase in cash, cash equivalents, and restricted cash 44.1 90.1
Cash, cash equivalents, and restricted cash at beginning of period 897.7 942.7
Cash, cash equivalents, and restricted cash at end of period $ 941.8 $ 1,032.8
[1] The prior period amount has been reclassified to conform to the current period presentation.
v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Shares
Common Stock and Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance (in shares) at Dec. 31, 2021   321.6      
Balance at Dec. 31, 2021 $ 4,316.9   $ 6,972.6 $ (2.1) $ (2,653.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 55.7       55.7
Other comprehensive income, net 13.8     13.8  
Issuance of common stock (in shares)   4.8      
Issuance of common stock 28.6   28.6    
Repurchase and retirement of common stock (in shares)   (3.6)      
Repurchase and retirement of common stock (126.3)   (46.3)   (80.0)
Share-based compensation expense 45.7   45.7    
Payments of cash dividends (67.5)   (67.5)    
Balance (in shares) at Mar. 31, 2022   322.8      
Balance at Mar. 31, 2022 $ 4,266.9   6,933.1 11.7 (2,677.9)
Balance (in shares) at Dec. 31, 2022 322.9 322.9      
Balance at Dec. 31, 2022 $ 4,475.1   6,846.4 4.2 (2,375.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 85.4       85.4
Other comprehensive income, net 4.1     4.1  
Issuance of common stock (in shares)   3.3      
Issuance of common stock 31.1   31.1    
Repurchase and retirement of common stock (in shares)   (4.8)      
Repurchase and retirement of common stock (151.3)   (60.2)   (91.1)
Share-based compensation expense 61.4   61.4    
Payments of cash dividends $ (70.6)   (70.6)    
Balance (in shares) at Mar. 31, 2023 321.4 321.4      
Balance at Mar. 31, 2023 $ 4,435.2   $ 6,808.1 $ 8.3 $ (2,381.2)
v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]    
Cash dividends (in dollars per share) $ 0.22 $ 0.21
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies
Note 1. Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The Condensed Consolidated Financial Statements of Juniper Networks, Inc. (the “Company” or “Juniper”) were prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The Condensed Consolidated Balance Sheet as of December 31, 2022 has been derived from the audited Consolidated Financial Statements at that date. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023, or any future period.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the audited Consolidated Financial Statements and accompanying notes in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"). We have evaluated all subsequent events through the date these condensed consolidated financial statements were issued.

The preparation of the financial statements and related disclosures in accordance with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates under different assumptions or conditions.

Certain prior period amounts have been reclassified to conform to the current period's presentation. None of these reclassifications had a material impact to the unaudited Condensed Consolidated Financial Statements.

Summary of Significant Accounting Policies

There have been no significant changes to the Company's significant accounting policies described in Note 1, Description of Business, Basis of Presentation and Significant Accounting Policies, in Notes to Consolidated Financial Statements in Item 8 of Part II of the Form 10-K for the fiscal year ended December 31, 2022.
v3.23.1
Cash Equivalents and Investments
3 Months Ended
Mar. 31, 2023
Cash Equivalents and Investments [Abstract]  
Cash Equivalents and Investments
Note 2. Cash Equivalents and Investments

Investments in Available-for-Sale Debt Securities

The following table summarizes the Company's unrealized gains and losses and fair value of investments designated as available-for-sale debt securities as of March 31, 2023 and December 31, 2022 (in millions):
As of March 31, 2023
As of December 31, 2022
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Fixed income securities:
Asset-backed and mortgage-backed securities$24.6 $— $(0.8)$23.8 $37.8 $— $(1.2)$36.6 
Corporate debt securities210.8 — (5.2)205.6 277.5 — (7.1)270.4 
Foreign government debt securities
8.8 — (0.3)8.5 8.8 — (0.4)8.4 
Time deposits89.7 — — 89.7 70.6 — — 70.6 
U.S. government agency securities
18.6 — (0.4)18.2 18.6 — (0.6)18.0 
U.S. government securities5.0 — (0.1)4.9 9.0 — (0.2)8.8 
Total fixed income securities
357.5 — (6.8)350.7 422.3 — (9.5)412.8 
Privately-held debt and redeemable preferred stock securities20.7 37.4 — 58.1 15.5 37.4 — 52.9 
Total available-for-sale debt securities
$378.2 $37.4 $(6.8)$408.8 $437.8 $37.4 $(9.5)$465.7 
Reported as:
Cash equivalents$89.7 $— $— $89.7 $70.6 $— $— $70.6 
Short-term investments171.4 — (3.0)168.4 205.9 — (3.3)202.6 
Long-term investments96.4 — (3.8)92.6 145.8 — (6.2)139.6 
Other long-term assets20.7 37.4 — 58.1 15.5 37.4 — 52.9 
Total$378.2 $37.4 $(6.8)$408.8 $437.8 $37.4 $(9.5)$465.7 


The following table presents the contractual maturities of the Company's total fixed income securities as of March 31, 2023 (in millions):
 Amortized
Cost
Estimated Fair
Value
Due in less than one year$261.1 $258.1 
Due between one and five years96.4 92.6 
Total$357.5 $350.7 


As of March 31, 2023, the Company's unrealized loss of $6.8 million resulted from 216 investments, of which losses aggregating $0.2 million were from investments in an unrealized loss position for less than 12 months, and $6.6 million were from investments in an unrealized loss position for more than 12 months. The gross unrealized losses related to these investments were primarily due to changes in market interest rates. The Company anticipates that it will recover the entire amortized cost basis of such available-for-sale debt securities and has determined that no allowance for credit losses was required to be recognized during the three months ended March 31, 2023 and March 31, 2022.
During the three months ended March 31, 2023 and March 31, 2022, there were no material gross realized gains or losses from available-for-sale debt securities.

Investments in Equity Securities

The following table presents the Company's investments in equity securities as of March 31, 2023 and December 31, 2022 (in millions):
As of
March 31,
2023
December 31,
2022
Equity investments with readily determinable fair value:
Money market funds$496.7 $420.8 
Mutual funds31.9 28.1 
Publicly-traded equity securities6.5 7.7 
Equity investments without readily determinable fair value130.7 137.7 
Equity investment under the equity method of accounting33.9 36.0 
Total equity securities$699.7 $630.3 
Reported as:
Cash equivalents$496.7 $420.8 
Short-term investments6.5 7.7 
Prepaid expenses and other current assets2.5 2.4 
Other long-term assets194.0 199.4 
Total$699.7 $630.3 

For the three months ended March 31, 2023 and March 31, 2022, there were no material unrealized gains or losses recognized for equity investments with readily determinable fair value or equity investments without readily determinable fair value. For the three months ended March 31, 2023, the loss recognized from the equity method investment was $2.1 million.

Restricted Cash and Investments

The Company has restricted cash and investments for: (i) amounts under the Company's non-qualified deferred compensation plan for senior-level employees; (ii) amounts held under the Company's short-term disability plan in California; and (iii) amounts held in escrow accounts, as required in connection with certain acquisitions. Restricted investments consist of equity investments. As of March 31, 2023, the carrying value of restricted cash and investments was $50.1 million, of which $18.4 million was included in prepaid expenses and other current assets, and $31.7 million was included in other long-term assets on the Condensed Consolidated Balance Sheets.

The following table provides a reconciliation of cash, cash equivalents, and restricted cash included in the Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 (in millions):
As of
March 31,
2023
December 31,
2022
Cash and cash equivalents$923.5 $880.1 
Restricted cash included in prepaid expenses and other current assets15.9 15.2 
Restricted cash included in other long-term assets2.4 2.4 
Total cash, cash equivalents, and restricted cash$941.8 $897.7 
v3.23.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 3. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table provides a summary of assets and liabilities measured at fair value on a recurring basis and as reported in the Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 (in millions):
Fair Value Measurements at
March 31, 2023
Fair Value Measurements at
December 31, 2022
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Assets:
Available-for-sale debt securities:
Asset-backed and mortgage-backed securities$— $23.8 $— $23.8 $— $36.6 $— $36.6 
Corporate debt securities — 205.6 — 205.6 — 270.4 — 270.4 
Foreign government debt securities— 8.5 — 8.5 — 8.4 — 8.4 
Time deposits— 89.7 — 89.7 — 70.6 — 70.6 
U.S. government agency securities— 18.2 — 18.2 — 18.0 — 18.0 
U.S. government securities4.9 — — 4.9 8.8 — — 8.8 
Privately-held debt and redeemable preferred stock securities— — 58.1 58.1 — — 52.9 52.9 
Total available-for-sale debt securities4.9 345.8 58.1 408.8 8.8 404.0 52.9 465.7 
Equity securities:
Money market funds496.7 — — 496.7 420.8 — — 420.8 
Mutual funds31.9 — — 31.9 28.1 — — 28.1 
Publicly-traded equity securities6.5 — — 6.5 7.7 — — 7.7 
Total equity securities535.1 — — 535.1 456.6 — — 456.6 
Derivative assets:
Foreign exchange contracts— 1.9 — 1.9 — 1.3 — 1.3 
Interest rate contracts— 111.4 — 111.4 — 125.4 — 125.4 
Total derivative assets— 113.3 — 113.3 — 126.7 — 126.7 
Total assets measured at fair value on a recurring basis$540.0 $459.1 $58.1 $1,057.2 $465.4 $530.7 $52.9 $1,049.0 
Liabilities:
Derivative liabilities:
Foreign exchange contracts$— $(26.4)$— $(26.4)$— $(37.6)$— $(37.6)
Interest rate contracts— (72.4)— (72.4)— (87.4)— (87.4)
Total derivative liabilities— (98.8)— (98.8)— (125.0)— (125.0)
Total liabilities measured at fair value on a recurring basis$— $(98.8)$— $(98.8)$— $(125.0)$— $(125.0)
Fair Value Measurements at
March 31, 2023
Fair Value Measurements at
December 31, 2022
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Total assets, reported as:
Cash equivalents$496.7 $89.7 $— $586.4 $420.8 $70.6 $— $491.4 
Short-term investments9.5 165.4 — 174.9 14.6 195.7 — 210.3 
Long-term investments1.9 90.7 — 92.6 1.9 137.7 — 139.6 
Prepaid expenses and other current assets
2.5 1.2 — 3.7 2.4 0.8 — 3.2 
Other long-term assets29.4 112.1 58.1 199.6 25.7 125.9 52.9 204.5 
Total assets measured at fair value
$540.0 $459.1 $58.1 $1,057.2 $465.4 $530.7 $52.9 $1,049.0 
Total liabilities, reported as:
Other accrued liabilities$— $(22.6)$— $(22.6)$— $(32.5)$— $(32.5)
Other long-term liabilities— (76.2)— (76.2)— (92.5)— (92.5)
Total liabilities measured at fair value on a recurring basis
$— $(98.8)$— $(98.8)$— $(125.0)$— $(125.0)

The Company's Level 2 available-for-sale debt securities are priced using quoted market prices for similar instruments or non-binding market prices that are corroborated by observable market data. The Company uses inputs such as actual trade data, benchmark yields, broker/dealer quotes, or alternative pricing sources with reasonable levels of price transparency, which are obtained from quoted market prices, independent pricing vendors, or other sources, to determine the ultimate fair value of these assets. The Company's derivative instruments are classified as Level 2, as they are not actively traded and are valued using pricing models that use observable market inputs. During the three months ended March 31, 2023, the Company had no transfers into or out of Level 3 of the fair value hierarchy of its assets or liabilities measured at fair value.

The Company's privately-held debt and redeemable preferred stock securities are classified as Level 3 assets due to the lack of observable inputs to determine fair value. The Company estimates the fair value of its privately-held debt and redeemable preferred stock securities on a recurring basis using an analysis of the financial condition and near-term prospects of the investee, including recent valuations at the time of financing activities and the investee's capital structure. During the three months ended March 31, 2023, there were no significant activities related to privately-held debt and redeemable preferred stock securities.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

The Company's investments in equity securities without readily determinable fair value are classified as Level 3 assets due to the lack of observable inputs to determine fair value. The Company estimates the fair value of equity securities without readily determinable fair value, and investments accounted for under the equity method of accounting, on a nonrecurring basis using an analysis of the financial condition and near-term prospects of the investee, including recent financing activities and the investee's capital structure. As of March 31, 2023, there have been no material upward or downward adjustments for price changes to the equity securities without readily determinable fair value.

Certain of the Company's assets, including intangible assets and goodwill, are measured at fair value on a nonrecurring basis. There were no significant impairment charges recognized during the three months ended March 31, 2023.

As of March 31, 2023 and December 31, 2022, the Company had no liabilities required to be measured at fair value on a nonrecurring basis.
Assets and Liabilities Not Measured at Fair Value

The carrying amounts of the Company's accounts receivable, accounts payable, and other accrued liabilities approximate fair value due to their short maturities. As of March 31, 2023 and December 31, 2022, the estimated fair value of the Company's total outstanding debt in the Condensed Consolidated Balance Sheets was $1,557.0 million and $1,485.6 million, respectively, based on observable market inputs (Level 2).
v3.23.1
Derivative Instruments
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 4. Derivative Instruments

The Company uses derivative instruments to manage a variety of risks, including risks related to fluctuations in foreign currency exchange rates and interest rates on debt instruments. We do not use derivative financial instruments for speculative purposes.

The notional amount of the Company's derivative instruments is summarized as follows (in millions):
 As of
 March 31,
2023
December 31,
2022
Designated derivatives:
Cash flow hedges:
Foreign currency contracts
$810.2 $775.9 
Interest rate lock contracts
650.0 650.0 
Fair value hedges:
Interest rate swap contracts
600.0 600.0 
Total designated derivatives
2,060.2 2,025.9 
Non-designated derivatives198.6 163.5 
Total$2,258.8 $2,189.4 

The fair value of derivative instruments on the Condensed Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationMarch 31,
2023
December 31,
2022
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$1.2 $0.7 
Foreign currency contracts Other long-term assets0.7 0.5 
Interest rate lock contracts Other long-term assets111.4 125.4 
Total derivatives designated as hedging instruments$113.3 $126.6 
Derivatives not designated as hedging instrumentsOther current assets0.1 0.1 
Total derivative assets$113.4 $126.7 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$22.5 $32.3 
Foreign currency contracts Other long-term liabilities3.8 5.1 
Interest rate swap contractsOther long-term liabilities72.4 87.4 
Total derivatives designated as hedging instruments$98.7 $124.8 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.1 0.2 
Total derivative liabilities$98.8 $125.0 
Offsetting of Derivative Instruments

The Company presents its derivative instruments at gross fair values in the Consolidated Balance Sheets. As of March 31, 2023 and December 31, 2022, the potential effects of set-off associated with the derivative contracts would be a reduction to both derivative assets and derivative liabilities by $61.8 million and $73.8 million, respectively.

Designated Derivatives

The Company uses foreign currency forward contracts or options contracts to hedge the Company's planned cost of revenues and operating expenses denominated in foreign currencies. These derivatives are designated as cash flow hedges and typically have maturities of thirty-six months or less.

The Company enters into interest rate swaps, designated as fair value hedges, to convert the fixed interest rates of certain Senior Notes ("Notes") to floating interest rates. In April 2021, the Company entered into swaps for an aggregate notional amount of $300.0 million for its fixed-rate Notes maturing in December 2030 in addition to the swaps entered in 2019 for an aggregate notional amount of $300.0 million for its fixed-rate Notes maturing in March 2041. The interest rate swaps will expire within eight years.

In 2020, the Company entered into interest rate locks with large financial institutions, which fix the benchmark interest rates of future debt issuances for an aggregate notional amount of $650.0 million. These contracts are designated as cash flow hedges and are expected to terminate within three years.

Effect of Derivative Instruments on the Condensed Consolidated Statements of Operations

For cash flow hedges, the Company recognized an unrealized loss of $9.9 million and an unrealized gain of $28.1 million in accumulated other comprehensive income for the effective portion of its derivative instruments during the three months ended March 31, 2023 and March 31, 2022, respectively.

For foreign currency contracts, the Company reclassified a loss of $7.8 million and a gain of $0.4 million out of accumulated other comprehensive income to cost of revenues and operating expenses in the Condensed Consolidated Statements of Operations during the three months ended March 31, 2023 and March 31, 2022, respectively. As of March 31, 2023, an estimated $21.4 million of unrealized net loss within accumulated other comprehensive income is expected to be reclassified into earnings within the next twelve months.

Non-Designated Derivatives

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. These foreign exchange forward contracts typically have maturities of approximately one to seven months. The outstanding non-designated derivative instruments are carried at fair value. Changes in the fair value of these derivatives, which were recorded in Other expense, net within the Condensed Consolidated Statements of Operations, were not material during the three months ended March 31, 2023 and March 31, 2022.
v3.23.1
Other Financial Information
3 Months Ended
Mar. 31, 2023
Other Financial Information [Abstract]  
Other Financial Information
Note 5. Other Financial Information

Total Inventory

Total inventory consisted of the following (in millions):
As of
March 31,
2023
December 31,
2022
Production and service materials$548.8 $479.6 
Finished goods239.9 163.3 
Total inventory$788.7 $642.9 
Reported as:
Inventory$761.5 $619.4 
Other long-term assets27.2 23.5 
Total inventory$788.7 $642.9 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in millions):
As of
March 31,
2023
December 31,
2022
Contract manufacturer deposits$425.3 $434.7 
Prepaid expenses130.5 104.3 
Other current assets180.6 141.0 
Total prepaid expenses and other current assets$736.4 $680.0 

Warranties

Changes during the three months ended March 31, 2023 in the Company’s warranty reserve as reported within other accrued liabilities in the Condensed Consolidated Balance Sheets were as follows (in millions):

Balance as of December 31, 2022
$29.5 
Provisions made during the period7.6 
Actual costs incurred during the period(8.0)
Balance as of March 31, 2023
$29.1 
Deferred Revenue

Details of the Company's deferred revenue, as reported in the Condensed Consolidated Balance Sheets, were as follows (in millions):
As of
March 31,
2023
December 31,
2022
Deferred product revenue, net$95.8 $108.8 
Deferred service revenue, net1,664.1 1,554.3 
Total$1,759.9 $1,663.1 
Reported as:
Current$1,074.3 $1,020.5 
Long-term685.6 642.6 
Total$1,759.9 $1,663.1 

Revenue

See Note 10, Segments, for disaggregated revenue by customer solution, customer vertical, and geographic region.

Product revenue of $19.2 million included in deferred revenue at January 1, 2023 was recognized during the three months ended March 31, 2023. Service revenue of $315.2 million included in deferred revenue at January 1, 2023 was recognized during the three months ended March 31, 2023.

Remaining Performance Obligations

Remaining Performance Obligations ("RPO") are comprised mainly of deferred product and service revenue, and to a lesser extent, unbilled service revenue from non-cancellable contracts for which the Company has not invoiced and has an obligation to perform, and for which revenue has not yet been recognized in the financial statements. Our RPO does not include backlog.

The following table summarizes the breakdown of RPO as of March 31, 2023 and when the Company expects to recognize the amounts as revenue (in millions):
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
Product$99.0 $80.6 $14.6 $3.8 
Service1,672.5 1,005.4 507.2 159.9 
Total$1,771.5 $1,086.0 $521.8 $163.7 



Deferred Contract Cost

We capitalize direct and incremental costs incurred to acquire contracts, primarily sales commissions, for which the associated revenue is expected to be recognized in future periods. We incur these costs in connection with both initial contracts and renewals. These costs are initially deferred, recorded as prepaid expenses and other current assets or other long-term assets, and are amortized over a period of benefit, which is typically over the term of the customer contracts or when product is delivered and revenue recognized. Commission expense is included in sales and marketing expenses in the accompanying Condensed Consolidated Statements of Operations.

Deferred contract cost was $48.6 million as of March 31, 2023. For the three months ended March 31, 2023, amortization expense for previously deferred commissions was $8.1 million, and there were no impairment charges recognized.
Other Expense, Net

Other expense, net, consisted of the following (in millions):
Three Months Ended March 31,
20232022
Interest income $9.5 $2.6 
Interest expense(19.2)(12.5)
Gain (loss) on investments, net0.9 (3.3)
Other0.2 0.3 
Other expense, net$(8.6)$(12.9)
v3.23.1
Restructuring Charges
3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Restructuring Charges
Note 6. Restructuring Charges

As of March 31, 2023, restructuring activities were immaterial. The following table provides a summary of changes in the restructuring liabilities (in millions):
December 31, 2022
ChargesCash
Payments
OtherMarch 31,
2023
Severance$3.0 $1.4 $(0.7)$— $3.7 
Contract terminations and facility exit-related3.1 (1.9)(2.1)1.4 0.5 
Total$6.1 $(0.5)$(2.8)$1.4 $4.2 
v3.23.1
Debt
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt
Note 7. Debt

Debt

The following table summarizes the Company's total debt (in millions, except percentages):
 As of
 Maturity DateEffective Interest RatesMarch 31,
2023
December 31,
2022
Senior Notes:
1.200% fixed-rate notes
December 20251.37 %$400.0 $400.0 
3.750% fixed-rate notes
August 20293.86 %500.0 500.0 
2.000% fixed-rate notes
December 20302.12 %400.0 400.0 
5.950% fixed-rate notes
March 20416.03 %400.0 400.0 
Total Notes1,700.0 1,700.0 
Unaccreted discount and debt issuance costs(10.8)(11.3)
Hedge accounting fair value adjustments(*)
(72.5)(87.4)
Total$1,616.7 $1,601.3 
________________________________
(*)     Represents the fair value adjustments for interest rate swaps with an aggregate notional amount of $600.0 million. These interest rate swaps convert the fixed interest rates of certain Notes to floating interest rates and are designated as fair value hedges. See Note 4, Derivative Instruments, for a discussion of the Company's interest rate swaps.

The Notes above are the Company’s senior unsecured and unsubordinated obligations, ranking equally in right of payment to all of the Company’s existing and future senior unsecured and unsubordinated indebtedness, and senior in right of payment to any of the Company’s future indebtedness that is expressly subordinated to the Notes.

Interest on the Notes is payable in cash semiannually. The effective interest rates for the Notes include the interest on the Notes, accretion of the discount, and amortization of issuance costs. The indenture and the supplemental indentures (together, the "indentures") that govern the Notes also contain various covenants, including limitations on the Company's ability to incur liens or enter into sale-leaseback transactions over certain dollar thresholds.

As of March 31, 2023, the Company was in compliance with all covenants in the indentures governing the Notes.

Revolving Credit Facility

The Company has an unsecured revolving credit facility that will expire in April 2024, which enables borrowings of up to $500.0 million, with an option to increase the amount of the credit facility by up to an additional $200.0 million, subject to the lenders' approval. As of March 31, 2023, the Company was in compliance with all covenants and no amounts were outstanding under its credit facility.
v3.23.1
Equity
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Equity
Note 8. Equity

The following table summarizes dividends paid and stock repurchases under the Company's stock repurchase program (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Dividends:
Per share$0.22 $0.21 
Amount$70.6 $67.5 
Repurchased under the 2018 Stock Repurchase Program:
Shares4.5 3.2 
Average price per share$31.20 $34.55 
Amount$140.0 $112.2 

Cash Dividends on Shares of Common Stock

During the three months ended March 31, 2023, the Company declared and paid a quarterly cash dividend of $0.22 per common share, totaling $70.6 million, on its outstanding common stock. Any future dividends, and the establishment of record and payment dates, are subject to approval by the Board of Directors of Juniper or an authorized committee thereof. See Note 14, Subsequent Events, for discussion of the Company's dividend declaration subsequent to March 31, 2023.

Stock Repurchase Activities

During the three months ended March 31, 2023, the Company repurchased 4.5 million shares of its common stock in the open market at an average price of $31.20 per share for an aggregate purchase price of $140.0 million under the 2018 Stock Repurchase Program.

As of March 31, 2023, there was approximately $0.5 billion of authorized funds remaining under the 2018 Stock Repurchase Program.

Future share repurchases under the 2018 Stock Repurchase Program will be subject to a review of the circumstances at that time and will be made from time to time in private transactions or open market purchases as permitted by securities laws and other legal requirements.

In addition to repurchases under the 2018 Stock Repurchase Program, the Company also withholds shares of common stock from certain employees in connection with the vesting of stock awards issued to such employees to satisfy applicable tax withholding requirements. Such withheld shares are treated as common stock repurchases in the Company's financial statements as they reduce the number of shares that would have been issued upon vesting. Repurchases associated with tax withholdings were $11.4 million and $14.1 million during the three months ended March 31, 2023 and March 31, 2022, respectively.
Accumulated Other Comprehensive Income, Net of Tax

The components of accumulated other comprehensive income, net of related taxes, for the three months ended March 31, 2023 were as follows (in millions):
Unrealized
Gains/Losses
on Available-for-
Sale Debt Securities
Unrealized
 Gains/Losses
on Cash Flow
Hedges
Foreign
Currency
Translation
Adjustments
Total
Balance as of December 31, 2022
$21.8 $61.5 $(79.1)$4.2 
Other comprehensive income (loss) before reclassifications2.1 (6.9)1.5 (3.3)
Amount reclassified from accumulated other comprehensive income— 7.4 — 7.4 
Other comprehensive income, net 2.1 0.5 1.5 4.1 
Balance as of March 31, 2023
$23.9 $62.0 $(77.6)$8.3 
v3.23.1
Employee Benefit Plans
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Employee Benefit Plans
Note 9. Employee Benefit Plans

Equity Incentive Plans

The Company has stock-based compensation plans pursuant to which it has granted stock options, restricted stock units (“RSUs”), and performance share awards (“PSAs”). The Company also maintains its 2008 Employee Stock Purchase Plan (the “ESPP”) for all eligible employees. As of March 31, 2023, 1.2 million and 4.9 million shares were available for future issuance under the Company's 2015 Equity Incentive Plan and the ESPP, respectively. In connection with past acquisitions, the Company has also assumed or substituted stock options, RSUs, restricted stock awards ("RSAs"), and PSAs.

RSU, RSA, and PSA Activities

The Company’s RSU, RSA, and PSA activities and related information as of and for the three months ended March 31, 2023 were as follows (in millions, except per share amounts and years):
Outstanding RSUs, RSAs, and PSAs
Number of SharesWeighted Average
Grant Date Fair
Value per Share
Weighted Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance as of December 31, 2022
20.2 $26.78 
Granted(*)
2.9 31.03 
Vested(1.9)26.57 
Canceled(0.9)25.83 
Balance as of March 31, 2023
20.3 $27.44 1.3$699.0 
________________________________
(*)    Includes 1.1 million service-based, 1.4 million performance-based, and 0.4 million market-based awards. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.

Employee Stock Purchase Plan

The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Shares purchased1.3 1.4 
Average exercise price per share$23.44 $20.07 
Share-Based Compensation Expense

Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and ESPP purchase rights was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
Three Months Ended March 31,
20232022
Cost of revenues - Product$1.7 $1.4 
Cost of revenues - Service4.7 4.5 
Research and development25.7 16.6 
Sales and marketing18.6 12.5 
General and administrative10.2 10.2 
Total$60.9 $45.2 

The following table summarizes share-based compensation expense by award type (in millions):
 Three Months Ended March 31,
 20232022
Stock options$0.8 $1.5 
RSUs, RSAs, and PSAs53.0 38.5 
ESPP purchase rights7.1 5.2 
Total$60.9 $45.2 
As of March 31, 2023, the total unrecognized compensation cost related to unvested share-based awards was $388.9 million to be recognized over a weighted-average period of 1.88 years.
v3.23.1
Segments
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segments
Note 10. Segments

The Company operates in one reportable segment. The Company's Chief Executive Officer, who is the chief operating decision maker, reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance, accompanied by disaggregated information about net revenues by customer solution, customer vertical, and geographic region as presented below.    

The following table presents net revenues by customer solution (in millions):
Three Months Ended March 31,
20232022
Customer Solutions:
Automated WAN Solutions$474.5 $390.7 
Cloud-Ready Data Center193.6 188.8 
AI-Driven Enterprise317.0 214.0 
Hardware Maintenance and Professional Services386.7 374.7 
Total $1,371.8 $1,168.2 

The following table presents net revenues by customer vertical (in millions):
 Three Months Ended March 31,
 20232022
Cloud$264.9 $307.0 
Service Provider549.9 428.0 
Enterprise557.0 433.2 
Total$1,371.8 $1,168.2 

The Company attributes revenues to a geographic region based on the customer’s shipping address. The following table presents net revenues by geographic region (in millions):
Three Months Ended March 31,
20232022
Americas:
United States$733.6 $603.6 
Other64.9 51.4 
Total Americas798.5 655.0 
Europe, Middle East, and Africa369.9 333.9 
Asia Pacific203.4 179.3 
Total$1,371.8 $1,168.2 

For the three months ended March 31, 2023, no customer accounted for more than 10% of total net revenues. For the three months ended March 31, 2022, one customer accounted for more than 10% of total net revenues.
v3.23.1
Income Taxes
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
Note 11. Income Taxes

The following table provides details of income taxes (in millions, except percentages):
 Three Months Ended March 31,
20232022
Income before income taxes$107.1 $45.6 
Income tax provision (benefit)$19.6 $(10.1)
Effective tax rate18.3 %(21.9)%

The Company’s effective tax rate differs from the federal statutory rate of 21% primarily due to the tax impact of state taxes, geographic mix of earnings including foreign-derived intangible income deductions and the capitalization of research and development ("R&D") expenditures, R&D and foreign tax credits, tax audit settlements, non-deductible compensation, cost sharing of stock-based compensation, and other transfer pricing adjustments.

The Company’s effective tax rate for the three months ended March 31, 2023 includes the net effect of one-time benefits.

The Company’s effective tax rate for the three months ended March 31, 2022 includes one-time benefits from tax legislative changes, assets held for sale, and excess tax benefits associated with stock-based compensation.

As of March 31, 2023, the total amount of gross unrecognized tax benefits was $117.2 million.

The Company engages in continuous discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. There is a greater than remote likelihood that the balance of the gross unrecognized tax benefits will decrease by up to $45.6 million within the next twelve months due to the completion of tax review cycles in various tax jurisdictions and lapses of applicable statutes of limitation.
The Company is currently under examination by the Internal Revenue Service and the India tax authorities for the 2017 through 2018 tax years and the 2012 through 2020 tax years, respectively.
v3.23.1
Net Income per Share
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Net Income per Share
Note 12. Net Income per Share

The Company computed basic and diluted net income per share as follows (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Numerator:
Net income$85.4 $55.7 
Denominator:
Weighted-average shares used to compute basic net income per share322.3 321.8 
Dilutive effect of employee stock awards6.8 9.3 
Weighted-average shares used to compute diluted net income per share329.1 331.1 
Net income per share:
Basic$0.26 $0.17 
Diluted$0.26 $0.17 
Anti-dilutive shares 2.9 2.2 
v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 13. Commitments and Contingencies

Commitments

Except for the items below, there have been no material changes to the Company's commitments compared to the commitments described in Note 15, Commitments and Contingencies, in Notes to Consolidated Financial Statements in Item 8 of Part II of the Form 10-K.

Purchase Commitments with Contract Manufacturers and Suppliers

In order to reduce manufacturing lead times and in the interest of having access to adequate component supply, the Company enters into agreements with contract manufacturers and certain suppliers to procure inventory based on the Company's requirements. A significant portion of the Company's purchase commitments arising from these agreements consists of firm and non-cancelable commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule, and adjust its requirements based on the Company's business needs prior to firm orders being placed. These purchase commitments totaled $2,298.8 million as of March 31, 2023.

Legal Proceedings

In the ordinary course of business, the Company is subject to various pending and potential investigations, disputes, litigations, and legal proceedings. The Company records an accrual for loss contingencies for legal proceedings when it believes that an unfavorable outcome is both (a) probable and (b) the amount or range of any possible loss is reasonably estimable. The Company intends to aggressively defend itself in any legal matters, and while the outcome of any pending matters is not currently determinable, the Company believes that none of its currently existing claims or proceedings are likely, individually or in the aggregate, to have a material adverse effect on its financial position. Notwithstanding the foregoing, there are many uncertainties associated with any litigation and these matters or any other third-party claims against the Company may cause the Company to incur costly litigation and/or substantial settlement charges. In addition, the resolution of any intellectual property litigation may require the Company to make royalty payments, which could adversely affect gross margins in future periods. If any of these events were to occur, the Company's business, financial condition, results of operations, and cash flows could be adversely affected. The actual liability in any such matters may be materially different from the Company's estimates, if any, which could result in the need to adjust the liability and record additional expenses.
v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note 14. Subsequent Events

Dividend Declaration

On April 25, 2023, the Company announced a cash dividend of $0.22 per share of common stock to be paid on June 22, 2023 to stockholders of record as of the close of business on June 1, 2023.
v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The Condensed Consolidated Financial Statements of Juniper Networks, Inc. (the “Company” or “Juniper”) were prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all information and footnotes required by U.S. GAAP for complete financial statements. The Condensed Consolidated Balance Sheet as of December 31, 2022 has been derived from the audited Consolidated Financial Statements at that date. In the opinion of management, all adjustments, including normal recurring accruals, considered necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023, or any future period.

These Condensed Consolidated Financial Statements and accompanying notes should be read in conjunction with the audited Consolidated Financial Statements and accompanying notes in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 (the "Form 10-K"). We have evaluated all subsequent events through the date these condensed consolidated financial statements were issued.
Use of Estimates The preparation of the financial statements and related disclosures in accordance with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates under different assumptions or conditions.
v3.23.1
Cash Equivalents and Investments (Tables)
3 Months Ended
Mar. 31, 2023
Cash Equivalents and Investments [Abstract]  
Schedule of Unrealized Gains and Losses and Fair Value of Available-For-Sale Debt Securities
The following table summarizes the Company's unrealized gains and losses and fair value of investments designated as available-for-sale debt securities as of March 31, 2023 and December 31, 2022 (in millions):
As of March 31, 2023
As of December 31, 2022
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Amortized
Cost
Gross Unrealized
Gains
Gross Unrealized
Losses
Estimated Fair
Value
Fixed income securities:
Asset-backed and mortgage-backed securities$24.6 $— $(0.8)$23.8 $37.8 $— $(1.2)$36.6 
Corporate debt securities210.8 — (5.2)205.6 277.5 — (7.1)270.4 
Foreign government debt securities
8.8 — (0.3)8.5 8.8 — (0.4)8.4 
Time deposits89.7 — — 89.7 70.6 — — 70.6 
U.S. government agency securities
18.6 — (0.4)18.2 18.6 — (0.6)18.0 
U.S. government securities5.0 — (0.1)4.9 9.0 — (0.2)8.8 
Total fixed income securities
357.5 — (6.8)350.7 422.3 — (9.5)412.8 
Privately-held debt and redeemable preferred stock securities20.7 37.4 — 58.1 15.5 37.4 — 52.9 
Total available-for-sale debt securities
$378.2 $37.4 $(6.8)$408.8 $437.8 $37.4 $(9.5)$465.7 
Reported as:
Cash equivalents$89.7 $— $— $89.7 $70.6 $— $— $70.6 
Short-term investments171.4 — (3.0)168.4 205.9 — (3.3)202.6 
Long-term investments96.4 — (3.8)92.6 145.8 — (6.2)139.6 
Other long-term assets20.7 37.4 — 58.1 15.5 37.4 — 52.9 
Total$378.2 $37.4 $(6.8)$408.8 $437.8 $37.4 $(9.5)$465.7 
Schedule of Maturities of Fixed Income Securities
The following table presents the contractual maturities of the Company's total fixed income securities as of March 31, 2023 (in millions):
 Amortized
Cost
Estimated Fair
Value
Due in less than one year$261.1 $258.1 
Due between one and five years96.4 92.6 
Total$357.5 $350.7 
Schedule of Investments in Equity Securities
The following table presents the Company's investments in equity securities as of March 31, 2023 and December 31, 2022 (in millions):
As of
March 31,
2023
December 31,
2022
Equity investments with readily determinable fair value:
Money market funds$496.7 $420.8 
Mutual funds31.9 28.1 
Publicly-traded equity securities6.5 7.7 
Equity investments without readily determinable fair value130.7 137.7 
Equity investment under the equity method of accounting33.9 36.0 
Total equity securities$699.7 $630.3 
Reported as:
Cash equivalents$496.7 $420.8 
Short-term investments6.5 7.7 
Prepaid expenses and other current assets2.5 2.4 
Other long-term assets194.0 199.4 
Total$699.7 $630.3 
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents, and restricted cash included in the Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 (in millions):
As of
March 31,
2023
December 31,
2022
Cash and cash equivalents$923.5 $880.1 
Restricted cash included in prepaid expenses and other current assets15.9 15.2 
Restricted cash included in other long-term assets2.4 2.4 
Total cash, cash equivalents, and restricted cash$941.8 $897.7 
v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table provides a summary of assets and liabilities measured at fair value on a recurring basis and as reported in the Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 (in millions):
Fair Value Measurements at
March 31, 2023
Fair Value Measurements at
December 31, 2022
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Assets:
Available-for-sale debt securities:
Asset-backed and mortgage-backed securities$— $23.8 $— $23.8 $— $36.6 $— $36.6 
Corporate debt securities — 205.6 — 205.6 — 270.4 — 270.4 
Foreign government debt securities— 8.5 — 8.5 — 8.4 — 8.4 
Time deposits— 89.7 — 89.7 — 70.6 — 70.6 
U.S. government agency securities— 18.2 — 18.2 — 18.0 — 18.0 
U.S. government securities4.9 — — 4.9 8.8 — — 8.8 
Privately-held debt and redeemable preferred stock securities— — 58.1 58.1 — — 52.9 52.9 
Total available-for-sale debt securities4.9 345.8 58.1 408.8 8.8 404.0 52.9 465.7 
Equity securities:
Money market funds496.7 — — 496.7 420.8 — — 420.8 
Mutual funds31.9 — — 31.9 28.1 — — 28.1 
Publicly-traded equity securities6.5 — — 6.5 7.7 — — 7.7 
Total equity securities535.1 — — 535.1 456.6 — — 456.6 
Derivative assets:
Foreign exchange contracts— 1.9 — 1.9 — 1.3 — 1.3 
Interest rate contracts— 111.4 — 111.4 — 125.4 — 125.4 
Total derivative assets— 113.3 — 113.3 — 126.7 — 126.7 
Total assets measured at fair value on a recurring basis$540.0 $459.1 $58.1 $1,057.2 $465.4 $530.7 $52.9 $1,049.0 
Liabilities:
Derivative liabilities:
Foreign exchange contracts$— $(26.4)$— $(26.4)$— $(37.6)$— $(37.6)
Interest rate contracts— (72.4)— (72.4)— (87.4)— (87.4)
Total derivative liabilities— (98.8)— (98.8)— (125.0)— (125.0)
Total liabilities measured at fair value on a recurring basis$— $(98.8)$— $(98.8)$— $(125.0)$— $(125.0)
Fair Value Measurements at
March 31, 2023
Fair Value Measurements at
December 31, 2022
Quoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
TotalQuoted Prices in
Active Markets For
Identical Assets
(Level 1)
Significant Other
Observable
Remaining Inputs
(Level 2)
Significant Other
Unobservable
Remaining Inputs
(Level 3)
Total
Total assets, reported as:
Cash equivalents$496.7 $89.7 $— $586.4 $420.8 $70.6 $— $491.4 
Short-term investments9.5 165.4 — 174.9 14.6 195.7 — 210.3 
Long-term investments1.9 90.7 — 92.6 1.9 137.7 — 139.6 
Prepaid expenses and other current assets
2.5 1.2 — 3.7 2.4 0.8 — 3.2 
Other long-term assets29.4 112.1 58.1 199.6 25.7 125.9 52.9 204.5 
Total assets measured at fair value
$540.0 $459.1 $58.1 $1,057.2 $465.4 $530.7 $52.9 $1,049.0 
Total liabilities, reported as:
Other accrued liabilities$— $(22.6)$— $(22.6)$— $(32.5)$— $(32.5)
Other long-term liabilities— (76.2)— (76.2)— (92.5)— (92.5)
Total liabilities measured at fair value on a recurring basis
$— $(98.8)$— $(98.8)$— $(125.0)$— $(125.0)
v3.23.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments The notional amount of the Company's derivative instruments is summarized as follows (in millions):
 As of
 March 31,
2023
December 31,
2022
Designated derivatives:
Cash flow hedges:
Foreign currency contracts
$810.2 $775.9 
Interest rate lock contracts
650.0 650.0 
Fair value hedges:
Interest rate swap contracts
600.0 600.0 
Total designated derivatives
2,060.2 2,025.9 
Non-designated derivatives198.6 163.5 
Total$2,258.8 $2,189.4 
Schedule of Derivative Assets at Fair Value
The fair value of derivative instruments on the Condensed Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationMarch 31,
2023
December 31,
2022
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$1.2 $0.7 
Foreign currency contracts Other long-term assets0.7 0.5 
Interest rate lock contracts Other long-term assets111.4 125.4 
Total derivatives designated as hedging instruments$113.3 $126.6 
Derivatives not designated as hedging instrumentsOther current assets0.1 0.1 
Total derivative assets$113.4 $126.7 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$22.5 $32.3 
Foreign currency contracts Other long-term liabilities3.8 5.1 
Interest rate swap contractsOther long-term liabilities72.4 87.4 
Total derivatives designated as hedging instruments$98.7 $124.8 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.1 0.2 
Total derivative liabilities$98.8 $125.0 
Schedule of Derivative Liabilities at Fair Value
The fair value of derivative instruments on the Condensed Consolidated Balance Sheets was as follows:
 As of
 Balance Sheet ClassificationMarch 31,
2023
December 31,
2022
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contractsOther current assets$1.2 $0.7 
Foreign currency contracts Other long-term assets0.7 0.5 
Interest rate lock contracts Other long-term assets111.4 125.4 
Total derivatives designated as hedging instruments$113.3 $126.6 
Derivatives not designated as hedging instrumentsOther current assets0.1 0.1 
Total derivative assets$113.4 $126.7 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contracts Other accrued liabilities$22.5 $32.3 
Foreign currency contracts Other long-term liabilities3.8 5.1 
Interest rate swap contractsOther long-term liabilities72.4 87.4 
Total derivatives designated as hedging instruments$98.7 $124.8 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.1 0.2 
Total derivative liabilities$98.8 $125.0 
v3.23.1
Other Financial Information (Tables)
3 Months Ended
Mar. 31, 2023
Other Financial Information [Abstract]  
Schedule of Inventories
Total inventory consisted of the following (in millions):
As of
March 31,
2023
December 31,
2022
Production and service materials$548.8 $479.6 
Finished goods239.9 163.3 
Total inventory$788.7 $642.9 
Reported as:
Inventory$761.5 $619.4 
Other long-term assets27.2 23.5 
Total inventory$788.7 $642.9 
Schedule of Prepaid Expenses and Other Current Assets
Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in millions):
As of
March 31,
2023
December 31,
2022
Contract manufacturer deposits$425.3 $434.7 
Prepaid expenses130.5 104.3 
Other current assets180.6 141.0 
Total prepaid expenses and other current assets$736.4 $680.0 
Schedule of Warranties
Changes during the three months ended March 31, 2023 in the Company’s warranty reserve as reported within other accrued liabilities in the Condensed Consolidated Balance Sheets were as follows (in millions):

Balance as of December 31, 2022
$29.5 
Provisions made during the period7.6 
Actual costs incurred during the period(8.0)
Balance as of March 31, 2023
$29.1 
Schedule of Deferred Revenue
Details of the Company's deferred revenue, as reported in the Condensed Consolidated Balance Sheets, were as follows (in millions):
As of
March 31,
2023
December 31,
2022
Deferred product revenue, net$95.8 $108.8 
Deferred service revenue, net1,664.1 1,554.3 
Total$1,759.9 $1,663.1 
Reported as:
Current$1,074.3 $1,020.5 
Long-term685.6 642.6 
Total$1,759.9 $1,663.1 
Schedule of Performance Obligation
The following table summarizes the breakdown of RPO as of March 31, 2023 and when the Company expects to recognize the amounts as revenue (in millions):
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
Product$99.0 $80.6 $14.6 $3.8 
Service1,672.5 1,005.4 507.2 159.9 
Total$1,771.5 $1,086.0 $521.8 $163.7 
Schedule of Other Expense
Other expense, net, consisted of the following (in millions):
Three Months Ended March 31,
20232022
Interest income $9.5 $2.6 
Interest expense(19.2)(12.5)
Gain (loss) on investments, net0.9 (3.3)
Other0.2 0.3 
Other expense, net$(8.6)$(12.9)
v3.23.1
Restructuring Charges (Tables)
3 Months Ended
Mar. 31, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Liabilities The following table provides a summary of changes in the restructuring liabilities (in millions):
December 31, 2022
ChargesCash
Payments
OtherMarch 31,
2023
Severance$3.0 $1.4 $(0.7)$— $3.7 
Contract terminations and facility exit-related3.1 (1.9)(2.1)1.4 0.5 
Total$6.1 $(0.5)$(2.8)$1.4 $4.2 
v3.23.1
Debt (Tables)
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Total Debt
The following table summarizes the Company's total debt (in millions, except percentages):
 As of
 Maturity DateEffective Interest RatesMarch 31,
2023
December 31,
2022
Senior Notes:
1.200% fixed-rate notes
December 20251.37 %$400.0 $400.0 
3.750% fixed-rate notes
August 20293.86 %500.0 500.0 
2.000% fixed-rate notes
December 20302.12 %400.0 400.0 
5.950% fixed-rate notes
March 20416.03 %400.0 400.0 
Total Notes1,700.0 1,700.0 
Unaccreted discount and debt issuance costs(10.8)(11.3)
Hedge accounting fair value adjustments(*)
(72.5)(87.4)
Total$1,616.7 $1,601.3 
________________________________
(*)     Represents the fair value adjustments for interest rate swaps with an aggregate notional amount of $600.0 million. These interest rate swaps convert the fixed interest rates of certain Notes to floating interest rates and are designated as fair value hedges. See Note 4, Derivative Instruments, for a discussion of the Company's interest rate swaps.
v3.23.1
Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Dividends Paid and Stock Repurchases and Retirements Under Stock Repurchase Program
The following table summarizes dividends paid and stock repurchases under the Company's stock repurchase program (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Dividends:
Per share$0.22 $0.21 
Amount$70.6 $67.5 
Repurchased under the 2018 Stock Repurchase Program:
Shares4.5 3.2 
Average price per share$31.20 $34.55 
Amount$140.0 $112.2 
Schedule of Accumulated Other Comprehensive Loss, Net of Taxes
The components of accumulated other comprehensive income, net of related taxes, for the three months ended March 31, 2023 were as follows (in millions):
Unrealized
Gains/Losses
on Available-for-
Sale Debt Securities
Unrealized
 Gains/Losses
on Cash Flow
Hedges
Foreign
Currency
Translation
Adjustments
Total
Balance as of December 31, 2022
$21.8 $61.5 $(79.1)$4.2 
Other comprehensive income (loss) before reclassifications2.1 (6.9)1.5 (3.3)
Amount reclassified from accumulated other comprehensive income— 7.4 — 7.4 
Other comprehensive income, net 2.1 0.5 1.5 4.1 
Balance as of March 31, 2023
$23.9 $62.0 $(77.6)$8.3 
v3.23.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Share Activity
The Company’s RSU, RSA, and PSA activities and related information as of and for the three months ended March 31, 2023 were as follows (in millions, except per share amounts and years):
Outstanding RSUs, RSAs, and PSAs
Number of SharesWeighted Average
Grant Date Fair
Value per Share
Weighted Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance as of December 31, 2022
20.2 $26.78 
Granted(*)
2.9 31.03 
Vested(1.9)26.57 
Canceled(0.9)25.83 
Balance as of March 31, 2023
20.3 $27.44 1.3$699.0 
________________________________
(*)    Includes 1.1 million service-based, 1.4 million performance-based, and 0.4 million market-based awards. The number of shares subject to performance-based and market-based conditions represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.
Schedule of Employee Stock Purchases through ESPP
The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Shares purchased1.3 1.4 
Average exercise price per share$23.44 $20.07 
Schedule of Employee Service Share-Based Compensation, Allocation of Recognized Period Costs
Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and ESPP purchase rights was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
Three Months Ended March 31,
20232022
Cost of revenues - Product$1.7 $1.4 
Cost of revenues - Service4.7 4.5 
Research and development25.7 16.6 
Sales and marketing18.6 12.5 
General and administrative10.2 10.2 
Total$60.9 $45.2 
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award
The following table summarizes share-based compensation expense by award type (in millions):
 Three Months Ended March 31,
 20232022
Stock options$0.8 $1.5 
RSUs, RSAs, and PSAs53.0 38.5 
ESPP purchase rights7.1 5.2 
Total$60.9 $45.2 
v3.23.1
Segments (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Financial Information for Each Segment
The following table presents net revenues by customer solution (in millions):
Three Months Ended March 31,
20232022
Customer Solutions:
Automated WAN Solutions$474.5 $390.7 
Cloud-Ready Data Center193.6 188.8 
AI-Driven Enterprise317.0 214.0 
Hardware Maintenance and Professional Services386.7 374.7 
Total $1,371.8 $1,168.2 

The following table presents net revenues by customer vertical (in millions):
 Three Months Ended March 31,
 20232022
Cloud$264.9 $307.0 
Service Provider549.9 428.0 
Enterprise557.0 433.2 
Total$1,371.8 $1,168.2 
Schedule of Net Revenues by Geographic Region
The Company attributes revenues to a geographic region based on the customer’s shipping address. The following table presents net revenues by geographic region (in millions):
Three Months Ended March 31,
20232022
Americas:
United States$733.6 $603.6 
Other64.9 51.4 
Total Americas798.5 655.0 
Europe, Middle East, and Africa369.9 333.9 
Asia Pacific203.4 179.3 
Total$1,371.8 $1,168.2 
v3.23.1
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
The following table provides details of income taxes (in millions, except percentages):
 Three Months Ended March 31,
20232022
Income before income taxes$107.1 $45.6 
Income tax provision (benefit)$19.6 $(10.1)
Effective tax rate18.3 %(21.9)%
v3.23.1
Net Income per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Share
The Company computed basic and diluted net income per share as follows (in millions, except per share amounts):
Three Months Ended March 31,
20232022
Numerator:
Net income$85.4 $55.7 
Denominator:
Weighted-average shares used to compute basic net income per share322.3 321.8 
Dilutive effect of employee stock awards6.8 9.3 
Weighted-average shares used to compute diluted net income per share329.1 331.1 
Net income per share:
Basic$0.26 $0.17 
Diluted$0.26 $0.17 
Anti-dilutive shares 2.9 2.2 
v3.23.1
Cash Equivalents and Investments - Available-For-Sale (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Available-for-sale debt securities:    
Amortized Cost $ 378.2 $ 437.8
Gross Unrealized Gains 37.4 37.4
Gross Unrealized Losses (6.8) (9.5)
Estimated Fair Value 408.8 465.7
Cash equivalents    
Available-for-sale debt securities:    
Amortized Cost 89.7 70.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 89.7 70.6
Short-term investments    
Available-for-sale debt securities:    
Amortized Cost 171.4 205.9
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (3.0) (3.3)
Estimated Fair Value 168.4 202.6
Long-term investments    
Available-for-sale debt securities:    
Amortized Cost 96.4 145.8
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (3.8) (6.2)
Estimated Fair Value 92.6 139.6
Other long-term assets    
Available-for-sale debt securities:    
Amortized Cost 20.7 15.5
Gross Unrealized Gains 37.4 37.4
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 58.1 52.9
Total fixed income securities    
Available-for-sale debt securities:    
Amortized Cost 357.5 422.3
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (6.8) (9.5)
Estimated Fair Value 350.7 412.8
Asset-backed and mortgage-backed securities    
Available-for-sale debt securities:    
Amortized Cost 24.6 37.8
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.8) (1.2)
Estimated Fair Value 23.8 36.6
Corporate debt securities    
Available-for-sale debt securities:    
Amortized Cost 210.8 277.5
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (5.2) (7.1)
Estimated Fair Value 205.6 270.4
Foreign government debt securities    
Available-for-sale debt securities:    
Amortized Cost 8.8 8.8
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.3) (0.4)
Estimated Fair Value 8.5 8.4
Time deposits    
Available-for-sale debt securities:    
Amortized Cost 89.7 70.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value 89.7 70.6
U.S. government agency securities    
Available-for-sale debt securities:    
Amortized Cost 18.6 18.6
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.4) (0.6)
Estimated Fair Value 18.2 18.0
U.S. government securities    
Available-for-sale debt securities:    
Amortized Cost 5.0 9.0
Gross Unrealized Gains 0.0 0.0
Gross Unrealized Losses (0.1) (0.2)
Estimated Fair Value 4.9 8.8
Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Amortized Cost 20.7 15.5
Gross Unrealized Gains 37.4 37.4
Gross Unrealized Losses 0.0 0.0
Estimated Fair Value $ 58.1 $ 52.9
v3.23.1
Cash Equivalents and Investments - Maturities of Fixed Income Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Amortized Cost    
Amortized Cost $ 378.2 $ 437.8
Estimated Fair Value    
Total 408.8 465.7
Total fixed income securities    
Amortized Cost    
Due in less than one year 261.1  
Due between one and five years 96.4  
Amortized Cost 357.5 422.3
Estimated Fair Value    
Due in less than one year 258.1  
Due between one and five years 92.6  
Total $ 350.7 $ 412.8
v3.23.1
Cash Equivalents and Investments - Narrative (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
investment
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Restricted Cash and Cash Equivalents Items [Line Items]      
Gross unrealized losses $ 6,800,000   $ 9,500,000
Total investments in unrealized loss position | investment 216    
Unrealized loss position, less than 12 months, accumulated loss $ 200,000    
Unrealized loss position, 12 months or longer, accumulated loss 6,600,000    
Equity securities, realized gain 0 $ 0  
Equity securities, realized loss 0 0  
Equity investments, unrealized gains 0 0  
Equity investments, unrealized losses 0 0  
Loss from equity method investment, net of tax 2,100,000 0  
Restricted cash and investments 50,100,000    
Prepaid expenses and other current assets      
Restricted Cash and Cash Equivalents Items [Line Items]      
Restricted cash and investments 18,400,000    
Other long-term assets      
Restricted Cash and Cash Equivalents Items [Line Items]      
Gross unrealized losses 0   $ 0
Restricted cash and investments 31,700,000    
Debt Securities      
Restricted Cash and Cash Equivalents Items [Line Items]      
Allowance for credit losses $ 0 $ 0  
v3.23.1
Cash Equivalents and Investments - Investments in Equity Securities (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments without readily determinable fair value $ 130.7 $ 137.7
Equity investment under the equity method of accounting 33.9 36.0
Total equity securities 699.7 630.3
Cash equivalents    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 496.7 420.8
Short-term investments    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 6.5 7.7
Prepaid expenses and other current assets    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 2.5 2.4
Other long-term assets    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Total equity securities 194.0 199.4
Money market funds    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value: 496.7 420.8
Mutual funds    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value: 31.9 28.1
Publicly-traded equity securities    
Debt Securities, Trading, and Equity Securities, FV-NI [Line Items]    
Equity investments with readily determinable fair value: $ 6.5 $ 7.7
v3.23.1
Cash Equivalents and Investments - Restricted Cash and Investments (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Restricted Cash and Cash Equivalents Items [Line Items]        
Cash and cash equivalents $ 923.5 $ 880.1    
Total cash, cash equivalents, and restricted cash 941.8 897.7 $ 1,032.8 $ 942.7
Prepaid expenses and other current assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted cash included in Prepaid expenses and other current and other long-term assets 15.9 15.2    
Other long-term assets        
Restricted Cash and Cash Equivalents Items [Line Items]        
Restricted cash included in Prepaid expenses and other current and other long-term assets $ 2.4 $ 2.4    
v3.23.1
Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Derivative assets:    
Derivative assets: $ 113.4 $ 126.7
Money market funds    
Equity securities:    
Equity securities 496.7 420.8
Publicly-traded equity securities    
Equity securities:    
Equity securities 6.5 7.7
Fair Value, Measurements, Recurring    
Available-for-sale debt securities:    
Available-for-sale debt securities 408.8 465.7
Equity securities:    
Equity securities 535.1 456.6
Derivative assets:    
Derivative assets: 113.3 126.7
Total assets measured at fair value on a recurring basis 1,057.2 1,049.0
Liabilities:    
Derivative liabilities: (98.8) (125.0)
Total liabilities measured at fair value on a recurring basis (98.8) (125.0)
Fair Value, Measurements, Recurring | Cash equivalents    
Derivative assets:    
Total assets measured at fair value on a recurring basis 586.4 491.4
Fair Value, Measurements, Recurring | Short-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 174.9 210.3
Fair Value, Measurements, Recurring | Long-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 92.6 139.6
Fair Value, Measurements, Recurring | Prepaid expenses and other current assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 3.7 3.2
Fair Value, Measurements, Recurring | Other long-term assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 199.6 204.5
Fair Value, Measurements, Recurring | Other accrued liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis (22.6) (32.5)
Fair Value, Measurements, Recurring | Other long-term liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis (76.2) (92.5)
Fair Value, Measurements, Recurring | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 1.9 1.3
Liabilities:    
Derivative liabilities: (26.4) (37.6)
Fair Value, Measurements, Recurring | Interest rate contracts    
Derivative assets:    
Derivative assets: 111.4 125.4
Liabilities:    
Derivative liabilities: (72.4) (87.4)
Fair Value, Measurements, Recurring | Asset-backed and mortgage-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 23.8 36.6
Fair Value, Measurements, Recurring | Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 205.6 270.4
Fair Value, Measurements, Recurring | Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 8.5 8.4
Fair Value, Measurements, Recurring | Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 89.7 70.6
Fair Value, Measurements, Recurring | U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 18.2 18.0
Fair Value, Measurements, Recurring | U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 4.9 8.8
Fair Value, Measurements, Recurring | Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.1 52.9
Fair Value, Measurements, Recurring | Money market funds    
Equity securities:    
Equity securities 496.7 420.8
Fair Value, Measurements, Recurring | Mutual funds    
Equity securities:    
Equity securities 31.9 28.1
Fair Value, Measurements, Recurring | Publicly-traded equity securities    
Equity securities:    
Equity securities 6.5 7.7
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1)    
Available-for-sale debt securities:    
Available-for-sale debt securities 4.9 8.8
Equity securities:    
Equity securities 535.1 456.6
Derivative assets:    
Derivative assets: 0.0 0.0
Total assets measured at fair value on a recurring basis 540.0 465.4
Liabilities:    
Derivative liabilities: 0.0 0.0
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Cash equivalents    
Derivative assets:    
Total assets measured at fair value on a recurring basis 496.7 420.8
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Short-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 9.5 14.6
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Long-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 1.9 1.9
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Prepaid expenses and other current assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 2.5 2.4
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Other long-term assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 29.4 25.7
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Other accrued liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Other long-term liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Interest rate contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Asset-backed and mortgage-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 4.9 8.8
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Money market funds    
Equity securities:    
Equity securities 496.7 420.8
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Mutual funds    
Equity securities:    
Equity securities 31.9 28.1
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets For Identical Assets (Level 1) | Publicly-traded equity securities    
Equity securities:    
Equity securities 6.5 7.7
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2)    
Available-for-sale debt securities:    
Available-for-sale debt securities 345.8 404.0
Equity securities:    
Equity securities 0.0 0.0
Derivative assets:    
Derivative assets: 113.3 126.7
Total assets measured at fair value on a recurring basis 459.1 530.7
Liabilities:    
Derivative liabilities: (98.8) (125.0)
Total liabilities measured at fair value on a recurring basis (98.8) (125.0)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Cash equivalents    
Derivative assets:    
Total assets measured at fair value on a recurring basis 89.7 70.6
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Short-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 165.4 195.7
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Long-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 90.7 137.7
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Prepaid expenses and other current assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 1.2 0.8
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Other long-term assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 112.1 125.9
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Other accrued liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis (22.6) (32.5)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Other long-term liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis (76.2) (92.5)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 1.9 1.3
Liabilities:    
Derivative liabilities: (26.4) (37.6)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Interest rate contracts    
Derivative assets:    
Derivative assets: 111.4 125.4
Liabilities:    
Derivative liabilities: (72.4) (87.4)
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Asset-backed and mortgage-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 23.8 36.6
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 205.6 270.4
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 8.5 8.4
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 89.7 70.6
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 18.2 18.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Money market funds    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Mutual funds    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Remaining Inputs (Level 2) | Publicly-traded equity securities    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3)    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.1 52.9
Equity securities:    
Equity securities 0.0 0.0
Derivative assets:    
Derivative assets: 0.0 0.0
Total assets measured at fair value on a recurring basis 58.1 52.9
Liabilities:    
Derivative liabilities: 0.0 0.0
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Cash equivalents    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Short-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Long-term investments    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Prepaid expenses and other current assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Other long-term assets    
Derivative assets:    
Total assets measured at fair value on a recurring basis 58.1 52.9
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Other accrued liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Other long-term liabilities    
Liabilities:    
Total liabilities measured at fair value on a recurring basis 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Foreign exchange contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Interest rate contracts    
Derivative assets:    
Derivative assets: 0.0 0.0
Liabilities:    
Derivative liabilities: 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Asset-backed and mortgage-backed securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Corporate debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Foreign government debt securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Time deposits    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | U.S. government agency securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | U.S. government securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Privately-held debt and redeemable preferred stock securities    
Available-for-sale debt securities:    
Available-for-sale debt securities 58.1 52.9
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Money market funds    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Mutual funds    
Equity securities:    
Equity securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Unobservable Remaining Inputs (Level 3) | Publicly-traded equity securities    
Equity securities:    
Equity securities $ 0.0 $ 0.0
v3.23.1
Fair Value Measurements - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Equity securities without readily determinable fair value, upward adjustment $ 0  
Equity securities without readily determinable fair value, downward adjustment 0  
Goodwill and intangible impairment 0  
Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial and nonfinancial liabilities, fair value disclosure 98,800,000 $ 125,000,000.0
Fair Value, Measurements, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial and nonfinancial liabilities, fair value disclosure 0 0
Significant Other Unobservable Remaining Inputs (Level 3) | Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial and nonfinancial liabilities, fair value disclosure 0 0
Significant Other Observable Remaining Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total outstanding debt, fair value 1,557,000,000 1,485,600,000
Significant Other Observable Remaining Inputs (Level 2) | Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial and nonfinancial liabilities, fair value disclosure 98,800,000 $ 125,000,000.0
Privately-held debt and redeemable preferred stock securities | Significant Other Unobservable Remaining Inputs (Level 3) | Fair Value, Measurements, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Unrealized gain (loss) on investments $ 0  
v3.23.1
Derivative Instruments - Notional Amount (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Apr. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Derivative [Line Items]          
Notional amount of derivatives $ 2,258,800,000 $ 2,189,400,000      
Designated derivatives          
Derivative [Line Items]          
Notional amount of derivatives 2,060,200,000 2,025,900,000      
Non-designated derivatives          
Derivative [Line Items]          
Notional amount of derivatives 198,600,000 163,500,000      
Foreign currency contracts | Cash flow hedges | Designated derivatives          
Derivative [Line Items]          
Notional amount of derivatives 810,200,000 775,900,000      
Interest rate lock contracts | Cash flow hedges | Designated derivatives          
Derivative [Line Items]          
Notional amount of derivatives 650,000,000.0 650,000,000.0 $ 300,000,000 $ 650,000,000 $ 300,000,000
Interest rate swap contracts | Fair value hedges          
Derivative [Line Items]          
Notional amount of derivatives 600,000,000        
Interest rate swap contracts | Fair value hedges | Designated derivatives          
Derivative [Line Items]          
Notional amount of derivatives $ 600,000,000.0 $ 600,000,000.0      
v3.23.1
Derivative Instruments - Fair Value of Derivative Assets and Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Derivative [Line Items]    
Derivative assets: $ 113.4 $ 126.7
Derivative liabilities: 98.8 125.0
Designated derivatives    
Derivative [Line Items]    
Derivative assets: 113.3 126.6
Derivative liabilities: 98.7 124.8
Designated derivatives | Other current assets | Foreign currency contracts    
Derivative [Line Items]    
Derivative assets: 1.2 0.7
Designated derivatives | Other long-term assets | Foreign currency contracts    
Derivative [Line Items]    
Derivative assets: 0.7 0.5
Designated derivatives | Other long-term assets | Interest rate lock contracts    
Derivative [Line Items]    
Derivative assets: 111.4 125.4
Designated derivatives | Other accrued liabilities | Foreign currency contracts    
Derivative [Line Items]    
Derivative liabilities: 22.5 32.3
Designated derivatives | Other long-term liabilities | Foreign currency contracts    
Derivative [Line Items]    
Derivative liabilities: 3.8 5.1
Designated derivatives | Other long-term liabilities | Interest rate swap contracts    
Derivative [Line Items]    
Derivative liabilities: 72.4 87.4
Derivatives not designated as hedging instruments | Other current assets    
Derivative [Line Items]    
Derivative assets: 0.1 0.1
Derivatives not designated as hedging instruments | Other accrued liabilities    
Derivative [Line Items]    
Derivative liabilities: $ 0.1 $ 0.2
v3.23.1
Derivative Instruments - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2020
Apr. 30, 2021
Dec. 31, 2019
Derivatives, Notional Amount [Line Items]              
Derivative asset, fair value, gross asset, period decrease $ 61,800,000 $ 73,800,000          
Derivative liability fair value gross liability period decrease 61,800,000 73,800,000          
Notional amount of derivatives 2,258,800,000 2,189,400,000 $ 2,258,800,000        
Foreign currency contracts              
Derivatives, Notional Amount [Line Items]              
Foreign currency forward contracts, amounts reclassified out of AOCI     $ (7,800,000) $ 400,000      
Foreign currency contracts | Minimum              
Derivatives, Notional Amount [Line Items]              
Maturity of foreign currency derivatives     1 month        
Foreign currency contracts | Maximum              
Derivatives, Notional Amount [Line Items]              
Maturity of foreign currency derivatives     7 months        
Designated derivatives              
Derivatives, Notional Amount [Line Items]              
Notional amount of derivatives 2,060,200,000 2,025,900,000 $ 2,060,200,000        
Cash flow hedges              
Derivatives, Notional Amount [Line Items]              
Derivative instruments, gain (loss) recognized in other comprehensive income (loss), effective portion     $ (9,900,000) $ 28,100,000      
Cash flow hedges | Designated derivatives              
Derivatives, Notional Amount [Line Items]              
Maximum maturities of cash flow hedge derivatives     36 months        
Losses expected to be reclassified into earnings within the next 12 months (21,400,000)            
Cash flow hedges | Designated derivatives | Interest rate lock contracts              
Derivatives, Notional Amount [Line Items]              
Notional amount of derivatives 650,000,000.0 650,000,000.0 $ 650,000,000.0   $ 650,000,000 $ 300,000,000 $ 300,000,000
Derivative, expiration period     8 years        
Swaps designated as cash flow hedges, expected termination period         3 years    
Cash flow hedges | Designated derivatives | Foreign currency contracts              
Derivatives, Notional Amount [Line Items]              
Notional amount of derivatives $ 810,200,000 $ 775,900,000 $ 810,200,000        
v3.23.1
Other Financial Information - Inventories, Net (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Schedule Of Inventory [Line Items]    
Production and service materials $ 548.8 $ 479.6
Finished goods 239.9 163.3
Total inventory 788.7 642.9
Inventory    
Schedule Of Inventory [Line Items]    
Total inventory 761.5 619.4
Other long-term assets    
Schedule Of Inventory [Line Items]    
Total inventory $ 27.2 $ 23.5
v3.23.1
Other Financial Information - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Other Financial Information [Abstract]    
Contract manufacturer deposits $ 425.3 $ 434.7
Prepaid expenses 130.5 104.3
Other current assets 180.6 141.0
Total prepaid expenses and other current assets $ 736.4 $ 680.0
v3.23.1
Other Financial Information - Warranties (Details)
$ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
Movement in Standard Product Warranty Accrual [Roll Forward]  
Balance as of December 31, 2022 $ 29.5
Provisions made during the period 7.6
Actual costs incurred during the period (8.0)
Balance as of March 31, 2023 $ 29.1
v3.23.1
Other Financial Information - Deferred Revenue (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Current $ 1,074.3 $ 1,020.5
Long-term 685.6 642.6
Total 1,759.9 1,663.1
Product    
Disaggregation of Revenue [Line Items]    
Total 95.8 108.8
Service    
Disaggregation of Revenue [Line Items]    
Total $ 1,664.1 $ 1,554.3
v3.23.1
Other Financial Information - Revenue, Remaining Performance Obligations and Deferred Contract Cost (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
Disaggregation of Revenue [Line Items]  
Deferred commission $ 48,600,000
Amortization of deferred commission 8,100,000
Impairment loss 0
Product  
Disaggregation of Revenue [Line Items]  
Contract with customer, liability, revenue recognized 19,200,000
Service  
Disaggregation of Revenue [Line Items]  
Contract with customer, liability, revenue recognized $ 315,200,000
v3.23.1
Other Financial Information - Revenue, Remaining Performance Obligation (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 1,771.5
Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period 99.0
Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period 1,672.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 1,086.0
Revenue recognition expected by period, satisfaction period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 80.6
Revenue recognition expected by period, satisfaction period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 1,005.4
Revenue recognition expected by period, satisfaction period 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 521.8
Revenue recognition expected by period, satisfaction period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 14.6
Revenue recognition expected by period, satisfaction period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 507.2
Revenue recognition expected by period, satisfaction period 2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 163.7
Revenue recognition expected by period, satisfaction period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01 | Product  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 3.8
Revenue recognition expected by period, satisfaction period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01 | Service  
Disaggregation of Revenue [Line Items]  
Revenue recognition expected by period $ 159.9
Revenue recognition expected by period, satisfaction period
v3.23.1
Other Financial Information - Other Expense, Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Other Financial Information [Abstract]    
Interest income $ 9.5 $ 2.6
Interest expense (19.2) (12.5)
Gain (loss) on investments, net 0.9 (3.3)
Other 0.2 0.3
Other expense, net $ (8.6) $ (12.9)
v3.23.1
Restructuring Charges - Changes to Restructuring Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Restructuring Reserve [Roll Forward]    
Charges $ (0.5) $ 8.8
2022 Restructuring Plan    
Restructuring Reserve [Roll Forward]    
Restructuring liability, beginning balance 6.1  
Charges (0.5)  
Cash Payments (2.8)  
Other 1.4  
Restructuring liability, ending balance 4.2  
Severance | 2022 Restructuring Plan    
Restructuring Reserve [Roll Forward]    
Restructuring liability, beginning balance 3.0  
Charges 1.4  
Cash Payments (0.7)  
Other 0.0  
Restructuring liability, ending balance 3.7  
Contract terminations and facility exit-related | 2022 Restructuring Plan    
Restructuring Reserve [Roll Forward]    
Restructuring liability, beginning balance 3.1  
Charges (1.9)  
Cash Payments (2.1)  
Other 1.4  
Restructuring liability, ending balance $ 0.5  
v3.23.1
Debt - Schedule of Debt (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Long-term debt $ 1,700,000,000 $ 1,700,000,000
Unaccreted discount and debt issuance costs (10,800,000) (11,300,000)
Hedge accounting fair value adjustments (72,500,000) (87,400,000)
Total 1,616,700,000 1,601,300,000
Notional amount of derivatives 2,258,800,000 2,189,400,000
Interest rate swap contracts | Fair value hedges    
Debt Instrument [Line Items]    
Notional amount of derivatives $ 600,000,000  
Senior notes | 1.200% fixed-rate notes    
Debt Instrument [Line Items]    
Stated interest rate 1.20%  
Effective Interest Rates 1.37%  
Long-term debt $ 400,000,000.0 400,000,000.0
Senior notes | 3.750% fixed-rate notes    
Debt Instrument [Line Items]    
Stated interest rate 3.75%  
Effective Interest Rates 3.86%  
Long-term debt $ 500,000,000.0 500,000,000.0
Senior notes | 2.000% fixed-rate notes    
Debt Instrument [Line Items]    
Stated interest rate 2.00%  
Effective Interest Rates 2.12%  
Long-term debt $ 400,000,000.0 400,000,000.0
Senior notes | 5.950% fixed-rate notes    
Debt Instrument [Line Items]    
Stated interest rate 5.95%  
Effective Interest Rates 6.03%  
Long-term debt $ 400,000,000.0 $ 400,000,000.0
v3.23.1
Debt - Revolving Credit Facility (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Line of Credit Facility [Line Items]    
Amount outstanding $ 1,616,700,000 $ 1,601,300,000
Unsecured Revolving Credit Facility | Line of Credit    
Line of Credit Facility [Line Items]    
Borrowing capacity (up to) 500,000,000  
Increase amount of borrowings, subject to lenders' approval (up to) 200,000,000  
Amount outstanding $ 0  
v3.23.1
Equity - Summary of Dividends Paid and Stock Repurchases and Retirements (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dividends:    
Per share (in dollars per share) $ 0.22 $ 0.21
Amount $ 70.6 $ 67.5
Repurchased under the 2018 Stock Repurchase Program:    
Amount $ 151.3 $ 126.3
Stock Repurchase Program 2018    
Repurchased under the 2018 Stock Repurchase Program:    
Shares (in shares) 4.5 3.2
Average price (in dollars per share) $ 31.20 $ 34.55
Amount $ 140.0 $ 112.2
v3.23.1
Equity - Cash Dividends on Shares of Common Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Equity [Abstract]    
Cash dividends declared (in dollars per share) $ 0.22  
Cash dividends declared $ 70.6 $ 67.5
v3.23.1
Equity - Stock Repurchase Activities (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accelerated Share Repurchases [Line Items]    
Common stock received, aggregate price $ 151.3 $ 126.3
Stock Repurchase Program 2018    
Accelerated Share Repurchases [Line Items]    
Stock repurchased (in shares) 4.5  
Common stock repurchased, average cost per share (in dollars per share) $ 31.20  
Common stock received, aggregate price $ 140.0 112.2
Stock repurchase program, remaining authorized repurchase amount 500.0  
Stock repurchased during period, tax withholding $ 11.4 $ 14.1
v3.23.1
Equity - Components of Accumulated Other Comprehensive (Loss) Income, Net of Tax (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance $ 4,475.1 $ 4,316.9
Other comprehensive income (loss) before reclassifications (3.3)  
Amount reclassified from accumulated other comprehensive income 7.4  
Other comprehensive income, net 4.1 13.8
Balance 4,435.2 4,266.9
Unrealized Gains/Losses on Available-for- Sale Debt Securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance 21.8  
Other comprehensive income (loss) before reclassifications 2.1  
Amount reclassified from accumulated other comprehensive income 0.0  
Other comprehensive income, net 2.1  
Balance 23.9  
Unrealized Gains/Losses on Cash Flow Hedges    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance 61.5  
Other comprehensive income (loss) before reclassifications (6.9)  
Amount reclassified from accumulated other comprehensive income 7.4  
Other comprehensive income, net 0.5  
Balance 62.0  
Foreign Currency Translation Adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance (79.1)  
Other comprehensive income (loss) before reclassifications 1.5  
Amount reclassified from accumulated other comprehensive income 0.0  
Other comprehensive income, net 1.5  
Balance (77.6)  
Accumulated Other Comprehensive Income (Loss)    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance 4.2 (2.1)
Other comprehensive income, net 4.1 13.8
Balance $ 8.3 $ 11.7
v3.23.1
Employee Benefit Plans - Equity Incentive Plan (Details)
shares in Millions
Mar. 31, 2023
shares
Equity incentive plan 2015  
Share-Based Compensation Plans  
Number of shares available for future issuance (in shares) 1.2
Employee stock purchase plan 2008  
Share-Based Compensation Plans  
Number of shares available for future issuance (in shares) 4.9
v3.23.1
Employee Benefit Plans - Restricted Stock Unit and Performance Share Award Activities (Details)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
RSUs, RSAs, and PSAs  
Number of Shares  
Balance at beginning of period (in shares) 20.2
Granted (in shares) 2.9
Vested (in shares) (1.9)
Canceled (in shares) (0.9)
Balance at end of period (in shares) 20.3
Weighted Average Grant Date Fair Value per Share  
Balance at beginning of period (in dollars per share) | $ / shares $ 26.78
Granted (in dollars per share) | $ / shares 31.03
Vested (in dollars per share) | $ / shares 26.57
Canceled (in dollars per share) | $ / shares 25.83
Balance at end of period (in dollars per share) | $ / shares $ 27.44
Weighted Average Remaining Contractual Term (In Years) 1 year 3 months 18 days
Aggregate Intrinsic Value | $ $ 699.0
Service-based RSUs  
Number of Shares  
Granted (in shares) 1.1
Performance Shares  
Number of Shares  
Granted (in shares) 1.4
Market-based RSUs  
Number of Shares  
Granted (in shares) 0.4
v3.23.1
Employee Benefit Plans - Employee Stock Purchase Plan (Details) - Employee stock purchase plan 2008 - $ / shares
shares in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Shares purchased (in shares) 1.3 1.4
Average exercise price per share (in dollars per share) $ 23.44 $ 20.07
v3.23.1
Employee Benefit Plans - Share Based Compensation by Cost and Expense Categories (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense $ 60.9 $ 45.2
Stock options    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 0.8 1.5
RSUs, RSAs, and PSAs    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 53.0 38.5
ESPP purchase rights    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 7.1 5.2
Cost of revenues - Product    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 1.7 1.4
Cost of revenues - Service    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 4.7 4.5
Research and development    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 25.7 16.6
Sales and marketing    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense 18.6 12.5
General and administrative    
Stock Based Compensation Expense Recorded in Cost and Expense Categories    
Share-based compensation expense $ 10.2 $ 10.2
v3.23.1
Employee Benefit Plans - Share Based Compensation by Share Based Payment Award Types (Details)
$ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
Share-Based Payment Arrangement [Abstract]  
Unrecognized compensation cost $ 388.9
Unrecognized compensation, weighted average recognition period 1 year 10 months 17 days
v3.23.1
Segments - Narrative (Details) - segment
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Segment Reporting [Abstract]    
Number of reportable segments 1  
Customer Concentration Risk | One Customer | Revenue Benchmark    
Concentration Risk [Line Items]    
Concentration risk, percentage   10.00%
v3.23.1
Segments - Revenue by Product (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Total net revenues $ 1,371.8 $ 1,168.2
Automated WAN Solutions    
Segment Reporting Information [Line Items]    
Total net revenues 474.5 390.7
Cloud-Ready Data Center    
Segment Reporting Information [Line Items]    
Total net revenues 193.6 188.8
AI-Driven Enterprise    
Segment Reporting Information [Line Items]    
Total net revenues 317.0 214.0
Hardware Maintenance and Professional Services    
Segment Reporting Information [Line Items]    
Total net revenues $ 386.7 $ 374.7
v3.23.1
Segments - Revenues by Customer Vertical (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Total net revenues $ 1,371.8 $ 1,168.2
Cloud    
Segment Reporting Information [Line Items]    
Total net revenues 264.9 307.0
Service Provider    
Segment Reporting Information [Line Items]    
Total net revenues 549.9 428.0
Enterprise    
Segment Reporting Information [Line Items]    
Total net revenues $ 557.0 $ 433.2
v3.23.1
Segments - Geographic (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Total net revenues $ 1,371.8 $ 1,168.2
Total Americas    
Segment Reporting Information [Line Items]    
Total net revenues 798.5 655.0
United States    
Segment Reporting Information [Line Items]    
Total net revenues 733.6 603.6
Other    
Segment Reporting Information [Line Items]    
Total net revenues 64.9 51.4
Europe, Middle East, and Africa    
Segment Reporting Information [Line Items]    
Total net revenues 369.9 333.9
Asia Pacific    
Segment Reporting Information [Line Items]    
Total net revenues $ 203.4 $ 179.3
v3.23.1
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Income before income taxes $ 107.1 $ 45.6
Income tax provision (benefit) $ 19.6 $ (10.1)
Effective tax rate 18.30% (21.90%)
Unrecognized tax benefits $ 117.2  
Unrecognized tax benefits, maximum decrease in the next twelve months (up to) $ 45.6  
v3.23.1
Net Income per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Numerator:    
Net income $ 85.4 $ 55.7
Denominator:    
Weighted-average shares used to compute basic net income per share (in shares) 322.3 321.8
Dilutive effect of employee stock awards (in shares) 6.8 9.3
Weighted-average shares used to compute diluted net income per share (in shares) 329.1 331.1
Net income per share:    
Basic (in dollars per share) $ 0.26 $ 0.17
Diluted (in dollars per share) $ 0.26 $ 0.17
Anti-dilutive shares (in shares) 2.9 2.2
v3.23.1
Commitments and Contingencies - Additional Information (Details)
$ in Millions
Mar. 31, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Purchase commitments $ 2,298.8
v3.23.1
Subsequent Events (Details) - $ / shares
3 Months Ended
Jun. 22, 2023
Apr. 25, 2023
Mar. 31, 2023
Mar. 31, 2022
Subsequent Event [Line Items]        
Cash dividends declared (in dollars per share)     $ 0.22  
Cash dividends (in dollars per share)     $ 0.22 $ 0.21
Forecast        
Subsequent Event [Line Items]        
Cash dividends (in dollars per share) $ 0.22      
Subsequent Event        
Subsequent Event [Line Items]        
Cash dividends declared (in dollars per share)   $ 0.22